Karen Green
Advanced in Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
Advanced in Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
2 Longview Avenue, 3rd Floor, 
White Plains, NY 

Overview

Dr. Karen Green graduated from New York University School of Medicine in 1988 and received residency training in Internal Medicine at The New York Hospital/Cornell Medical Center and Memorial Sloan Kettering Cancer Center. She completed a fellowship in Hematology/Oncology at New York Presbyterian Hospital/Cornell Medical Center. After completing her training in 1995, she spent eight years on the full-time faculty at New York Presbyterian Hospital/Cornell Medical Center, where she served as Assistant Professor of Medicine and specialized in breast cancer.

Dr. Green is rated as an Advanced provider by MediFind in the treatment of Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Her clinical research consists of participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
New York University
Residency
New York University Langone Medical Center
Specialties
Hematology
Licenses
Internal Medicine in NY
Board Certifications
American Board Of Internal Medicine
Fellowships
New York Hospital Presbyterian-Cornell Medical Ctr
Hospital Affiliations
White Plains Hospital Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CenterLight Healthcare
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Hamaspik
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Longevity Health Plan
  • MEDICARE SNP
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VNS Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

WPHPA Cancer and Blood Specialists of New York
2 Longview Avenue, 3rd Floor, White Plains, NY 10601
Other Locations
WPHPA Oncology & Hematology
2 Longview Avenue, 2nd Floor, White Plains, NY 10601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
View 8 Less Clinical Trials
Similar Doctors
Carol Lederman
Distinguished in Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
Distinguished in Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency

WPHPA Cancer And Blood Specialists Of New York

2 Longview Avenue, 3rd Floor, 
White Plains, NY 
 (0.5 miles away)
Languages Spoken:
English
Offers Telehealth

Dr. Lederman received her medical degree from Cornell Medical College and completed residency in Internal Medicine at The Mount Sinai Hospital in New York. After serving one year as Chief Resident in Internal Medicine at Elmhurst Hospital in Queens, she completed fellowship training in Hematology and Oncology at New York Medical College/Westchester Medical Center. She served New York Medical College as Assistant Clinical Professor for several years, as well as being an active member of the New York Blood Center Transfusion Service. Dr. Lederman is rated as a Distinguished provider by MediFind in the treatment of Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency. Her top areas of expertise are GTP Cyclohydrolase 1 Deficiency, Pseudocholinesterase Deficiency, Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency, and Deep Vein Thrombosis.

Joshua P. Raff
Advanced in Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
Advanced in Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency

WPHPA Oncology & Hematology

2 Longview Avenue, 2nd Floor, 
White Plains, NY 
 (0.5 miles away)
Languages Spoken:
English
Offers Telehealth

Joshua Raff, M.D. is the Director of the Digestive Cancer Program at White Plains Hospital, as well as the Leader of the Hospital's GI Cancer Program Conference. Dr. Raff received his medical degree from the Sackler School of Medicine at Tel Aviv University in 1997. He completed his residency in internal medicine at Montefiore Medical Center in the Bronx, and was a fellow of hematology and oncology at Albert Einstein College of Medicine from 2000-2003. Dr. Raff is rated as a Distinguished provider by MediFind in the treatment of Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency. His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Chronic Lymphocytic Leukemia (CLL), and Colorectal Cancer.

Distinguished in Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
Hematology Oncology | Hematology | Oncology
Distinguished in Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
Hematology Oncology | Hematology | Oncology

New York University

111 Broadway, 
New York, NY 
 (25.3 miles away)
Languages Spoken:
English
Offers Telehealth

Marc Braunstein is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Braunstein is rated as a Distinguished provider by MediFind in the treatment of Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency. His top areas of expertise are Multiple Myeloma, Schnitzler Syndrome, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Green's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 63 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile